Cargando…

Potential assistive technology preferences of informal caregivers of people with disability

BACKGROUND: Preferences of informal caregivers of people with neurocognitive disorders for technological solutions are important in user- centered design approaches. It is crucial to take into consideration the needs and preferences of users when developing new technology to facilitate their uptake....

Descripción completa

Detalles Bibliográficos
Autores principales:	Atoyebi, Oladele, Beaudoin, Maude, Routhier, François, Auger, Claudine, Demers, Louise, Wister, Andrew, Plante, Michelle, Mortenson, W Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	AGE-WELL Standard Submission
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164850/ https://www.ncbi.nlm.nih.gov/pubmed/37168036 http://dx.doi.org/10.1177/20556683231172671

Ejemplares similares

Joining semantic and augmented reality to design smart homes for assistance
por: Haidon, Corentin, et al.
Publicado: (2020)

Ethical research engagement with Indigenous communities
por: Billan, Jennifer, et al.
Publicado: (2020)

Development of a stick-on hip protector: A multiple methods study to improve hip protector design for older adults in the acute care environment
por: Post, E, et al.
Publicado: (2019)

Impact attenuation provided by older adult protective headwear products during simulated fall-related head impacts
por: Martel, Daniel R, et al.
Publicado: (2021)

Psychometric properties of a Power Mobility Caregiver Assistive Technology Outcome Measure
por: Mortenson, W. Ben, et al.
Publicado: (2017)

A stated preference survey to explore patient preferences for novel preventive migraine treatments
por: Hubig, Lena T., et al.
Publicado: (2022)

Mobility and Participation of People With Disabilities Using Mobility Assistive Technologies: Protocol for a Mixed-Methods Study
por: Routhier, François, et al.
Publicado: (2019)

Patient preference for early onset of efficacy of preventive migraine treatments
por: Ailani, Jessica, et al.
Publicado: (2022)

Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment
por: Fofi, Luisa, et al.
Publicado: (2022)

Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
por: Harris, Linda, et al.
Publicado: (2022)

The Neuropsychology of Cluster Headache: Cognition, Mood, Disability, and Quality of Life of Patients With Chronic and Episodic Cluster Headache
por: Torkamani, Mariam, et al.
Publicado: (2015)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

Components and Outcomes of Internet-Based Interventions for Caregivers of Older Adults: Systematic Review
por: Guay, Cassioppée, et al.
Publicado: (2017)

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disability
por: Lipton, Richard B., et al.
Publicado: (2016)

Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II
por: Dodick, David W., et al.
Publicado: (2020)

Effects of a caregiver-inclusive assistive technology intervention: a randomized controlled trial
por: Ben Mortenson, W., et al.
Publicado: (2018)

Effect of a tailored assistive technology intervention on older adults and their family caregiver: a pragmatic study protocol
por: Demers, Louise, et al.
Publicado: (2016)

Context awareness architecture for ambient-assisted living applications: Case study of nighttime wandering
por: Kenfack Ngankam, Hubert, et al.
Publicado: (2020)

A Qualitative Study to Assess the Content Validity of the 24‐Hour Migraine Quality of Life Questionnaire in Patients with Migraine
por: Speck, Rebecca M., et al.
Publicado: (2020)

Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study
por: Carlsen, Louise Ninett, et al.
Publicado: (2022)

A Real‐World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
por: Lombard, Louise, et al.
Publicado: (2020)

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies
por: Ashina, Messoud, et al.
Publicado: (2019)

Disasters in Europe: Inviting authors to submit scientific and practical papers on disasters in their country
Publicado: (2000)

PDA (Prolonged Depolarizing Afterpotential) - Defective Mutants: The Story of nina's and ina's—pinta and santa maria, Too
por: Pak, William L., et al.
Publicado: (2012)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
por: Tepper, Stewart J, et al.
Publicado: (2015)

A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine
por: Cady, Roger, et al.
Publicado: (2015)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
por: Cady, Roger K, et al.
Publicado: (2015)

Improved Pharmacokinetics of Sumatriptan With Breath Powered™ Nasal Delivery of Sumatriptan Powder
por: Obaidi, Mohammad, et al.
Publicado: (2013)

Severe Headache or Migraine History Is Inversely Correlated With Dietary Sodium Intake: NHANES 1999–2004
por: Pogoda, Janice M., et al.
Publicado: (2016)

Kinetic Oscillation Stimulation as Treatment of Acute Migraine: A Randomized, Controlled Pilot Study
por: Juto, Jan-Erik, et al.
Publicado: (2015)

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
por: Rothrock, John F, et al.
Publicado: (2014)

IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT
por: Facey, Karen, et al.
Publicado: (2015)

A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Maurea, Nicola, et al.
Publicado: (2016)

A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Spallarossa, Paolo, et al.
Publicado: (2016)

Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Dodick, David W., et al.
Publicado: (2016)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Robotic Near-Total Pancreatectomy for Nesidioblastosis after Bariatric Surgery
por: Macedo, Antonio Luiz de Vasconcellos, et al.
Publicado: (2016)

Screening of Two ADH4 Variations in a Swedish Cluster Headache Case–Control Material
por: Fourier, Carmen, et al.
Publicado: (2016)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data
por: Choong, Casey K., et al.
Publicado: (2017)

A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
por: Depre, Christophe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n93ski79mp5i5g2mgshfj1dbj5